Affiliation:
1. Department of Pharmacology and Addiction Research, Treatment & Training Center of Excellence, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA
Abstract
Objectives
There has been substantial and growing interest in the therapeutic utility of drugs acting at serotonin 2A subtype (5-HT2A) receptors, increasing the need for characterization of potential beneficial and adverse effects of such compounds. Although numerous studies have evaluated the possible rewarding and reinforcing effects of 5-HT2A receptor agonists, there have been relatively few studies on potential aversive effects.
Methods
The current study investigated punishing effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in four rhesus monkeys responding under a choice procedure in which responding on one lever delivered a sucrose pellet alone and responding on the other lever delivered a sucrose pellet plus an intravenous infusion of a range of doses of fentanyl (0.1–3.2 µg/kg/infusion), histamine (3.2–100 µg/kg/infusion), or DOM (3.2–100 µg/kg/infusion).
Results
When fentanyl was available, responding for a pellet plus an infusion increased dose dependently in all subjects, indicating a positive reinforcing effect of fentanyl. When histamine was available, responding for a pellet plus an infusion decreased in three of four subjects, indicating a punishing effect of histamine. Whether available before or after histamine, DOM did not systematically alter choice across the range of doses tested.
Conclusion
These results suggest that the 5-HT2A receptor agonist DOM has neither positive reinforcing nor punishing effects under a choice procedure that is sensitive to both processes.
Publisher
Ovid Technologies (Wolters Kluwer Health)